JP2005503763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005503763A5 JP2005503763A5 JP2002561497A JP2002561497A JP2005503763A5 JP 2005503763 A5 JP2005503763 A5 JP 2005503763A5 JP 2002561497 A JP2002561497 A JP 2002561497A JP 2002561497 A JP2002561497 A JP 2002561497A JP 2005503763 A5 JP2005503763 A5 JP 2005503763A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- fusion protein
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 24
- 102000004196 processed proteins & peptides Human genes 0.000 claims 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims 24
- 150000001413 amino acids Chemical group 0.000 claims 18
- 235000001014 amino acid Nutrition 0.000 claims 17
- 229940024606 amino acid Drugs 0.000 claims 16
- 102000037865 fusion proteins Human genes 0.000 claims 11
- 108020001507 fusion proteins Proteins 0.000 claims 11
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 4
- 229960001230 asparagine Drugs 0.000 claims 4
- 235000009582 asparagine Nutrition 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 229920001515 polyalkylene glycol Polymers 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- 239000004472 Lysine Substances 0.000 claims 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 102100026376 Artemin Human genes 0.000 claims 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000008100 Human Serum Albumin Human genes 0.000 claims 1
- 108091006905 Human Serum Albumin Proteins 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 230000004071 biological effect Effects 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000000539 dimer Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000000653 nervous system Anatomy 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 230000006576 neuronal survival Effects 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 231100000915 pathological change Toxicity 0.000 claims 1
- 230000036285 pathological change Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26607101P | 2001-02-01 | 2001-02-01 | |
| PCT/US2002/002319 WO2002060929A2 (en) | 2001-02-01 | 2002-01-25 | Polymer conjugates of neublastin and methods of using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008277469A Division JP4423338B2 (ja) | 2001-02-01 | 2008-10-28 | ニューブラスチンのポリマー結合体および同様の使用方法。 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005503763A JP2005503763A (ja) | 2005-02-10 |
| JP2005503763A5 true JP2005503763A5 (enExample) | 2005-12-22 |
| JP4259868B2 JP4259868B2 (ja) | 2009-04-30 |
Family
ID=23013042
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002561497A Expired - Fee Related JP4259868B2 (ja) | 2001-02-01 | 2002-01-25 | ニューブラスチンのポリマー結合体および同様の使用方法。 |
| JP2008277469A Expired - Fee Related JP4423338B2 (ja) | 2001-02-01 | 2008-10-28 | ニューブラスチンのポリマー結合体および同様の使用方法。 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008277469A Expired - Fee Related JP4423338B2 (ja) | 2001-02-01 | 2008-10-28 | ニューブラスチンのポリマー結合体および同様の使用方法。 |
Country Status (35)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7442370B2 (en) | 2001-02-01 | 2008-10-28 | Biogen Idec Ma Inc. | Polymer conjugates of mutated neublastin |
| BR0206852A (pt) * | 2001-02-01 | 2005-05-03 | Biogen Inc | Conjugados de polìmero de neublastina e métodos para uso dos mesmos |
| US7276580B2 (en) | 2001-03-12 | 2007-10-02 | Biogen Idec Ma Inc. | Neurotrophic factors |
| NZ529126A (en) * | 2001-03-28 | 2010-07-30 | Biogen Idec Inc | Use of neublastin polypeptides for treating allodynia, hyperalgesic pain and phantom pain |
| MXPA04006855A (es) * | 2002-01-18 | 2005-04-19 | Biogen Idec Inc | Compuestos de polimeros de polialquileno y usos de los mismos. |
| SI1594436T1 (sl) | 2003-01-31 | 2011-01-31 | Biogen Idec Inc | Mutirani neoblastin |
| ES2328640T3 (es) | 2003-04-18 | 2009-11-16 | Biogen Idec Ma Inc. | Neublastina conjugada con un polimero glicosilada. |
| WO2004108760A2 (en) | 2003-06-10 | 2004-12-16 | Nsgene A/S | Improved secretion of neublastin |
| US7598059B2 (en) | 2003-10-02 | 2009-10-06 | Biogen Idec Ma Inc. | Neublastin expression constructs |
| ATE472333T1 (de) * | 2004-08-19 | 2010-07-15 | Biogen Idec Inc | Rückfaltung von proteinen der transforming-growth-factor-beta-familie |
| UA92590C2 (uk) * | 2004-08-19 | 2010-11-25 | Байоджен Айдек Ма Інк. | Варіанти нейбластину |
| TWI501774B (zh) | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
| WO2007103182A2 (en) * | 2006-03-01 | 2007-09-13 | Biogen Idec Ma Inc. | Compostions and methods for administering gdnf ligand family proteins |
| CA2663300C (en) | 2006-09-15 | 2014-10-07 | Creabilis Therapeutics S.P.A. | Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1 |
| AU2008247637B2 (en) | 2007-05-01 | 2013-12-05 | Biogen Ma Inc. | Compositions and methods for increasing vascularization |
| TR201903707T4 (tr) * | 2011-11-02 | 2019-04-22 | Hoffmann La Roche | Aşırı yükleme ve elüsyon kromatografisi. |
| RU2488635C1 (ru) * | 2012-03-22 | 2013-07-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития | Способ получения рекомбинантного антиангиогенного полипептида |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6472178B1 (en) * | 1998-02-27 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof |
| US5770577A (en) * | 1994-11-14 | 1998-06-23 | Amgen Inc. | BDNF and NT-3 polypeptides selectively linked to polyethylene glycol |
| US6593133B1 (en) * | 1998-07-06 | 2003-07-15 | Nsgene A/S | Neurotrophic factors |
| EP1137774A2 (en) * | 1998-12-09 | 2001-10-04 | Amgen Inc. | Grnf4, a gdnf-related neurotrophic factor |
| BR0206852A (pt) * | 2001-02-01 | 2005-05-03 | Biogen Inc | Conjugados de polìmero de neublastina e métodos para uso dos mesmos |
-
2002
- 2002-01-25 BR BR0206852-4A patent/BR0206852A/pt not_active Application Discontinuation
- 2002-01-25 DK DK02714792T patent/DK1355936T3/da active
- 2002-01-25 CZ CZ20032080A patent/CZ20032080A3/cs unknown
- 2002-01-25 PL PL372101A patent/PL211162B1/pl unknown
- 2002-01-25 SK SK971-2003A patent/SK288123B6/sk not_active IP Right Cessation
- 2002-01-25 NZ NZ527863A patent/NZ527863A/en not_active IP Right Cessation
- 2002-01-25 CA CA2436407A patent/CA2436407C/en not_active Expired - Fee Related
- 2002-01-25 GE GE5240A patent/GEP20063916B/en unknown
- 2002-01-25 AR ARP020100279A patent/AR035077A1/es not_active Application Discontinuation
- 2002-01-25 HU HU0500637A patent/HU228973B1/hu not_active IP Right Cessation
- 2002-01-25 ES ES02714792T patent/ES2289091T3/es not_active Expired - Lifetime
- 2002-01-25 JP JP2002561497A patent/JP4259868B2/ja not_active Expired - Fee Related
- 2002-01-25 EE EEP200300355A patent/EE05537B1/xx not_active IP Right Cessation
- 2002-01-25 UA UAA200802148A patent/UA100967C2/ru unknown
- 2002-01-25 KR KR1020087022638A patent/KR100960063B1/ko not_active Expired - Fee Related
- 2002-01-25 WO PCT/US2002/002319 patent/WO2002060929A2/en not_active Ceased
- 2002-01-25 EA EA200300852A patent/EA009771B1/ru not_active IP Right Cessation
- 2002-01-25 UA UA2003088104A patent/UA82983C2/ru unknown
- 2002-01-25 RS YUP-610/03A patent/RS50857B/sr unknown
- 2002-01-25 EP EP02714792A patent/EP1355936B1/en not_active Expired - Lifetime
- 2002-01-25 TR TR2003/01208T patent/TR200301208T2/xx unknown
- 2002-01-25 AT AT02714792T patent/ATE365748T1/de active
- 2002-01-25 DE DE60220879T patent/DE60220879T2/de not_active Expired - Lifetime
- 2002-01-25 IL IL15694102A patent/IL156941A0/xx unknown
- 2002-01-25 KR KR1020037010127A patent/KR100872807B1/ko not_active Expired - Fee Related
- 2002-01-25 EP EP07110666A patent/EP1862475A1/en not_active Withdrawn
- 2002-01-25 MX MXPA03006805A patent/MXPA03006805A/es active IP Right Grant
- 2002-01-25 PT PT02714792T patent/PT1355936E/pt unknown
- 2002-01-25 SG SG200504719-6A patent/SG149685A1/en unknown
- 2002-01-25 AU AU2002247037A patent/AU2002247037B2/en not_active Ceased
- 2002-01-25 SI SI200230580T patent/SI1355936T1/sl unknown
- 2002-01-25 CN CN028077539A patent/CN1500095B/zh not_active Expired - Fee Related
- 2002-02-04 MY MYPI20020368A patent/MY143685A/en unknown
-
2003
- 2003-07-15 IL IL156941A patent/IL156941A/en not_active IP Right Cessation
- 2003-07-17 IS IS6879A patent/IS2867B/is unknown
- 2003-07-24 ZA ZA2003/05733A patent/ZA200305733B/en unknown
- 2003-08-01 NO NO20033441A patent/NO332150B1/no not_active IP Right Cessation
- 2003-08-19 BG BG108111A patent/BG66393B1/bg unknown
-
2007
- 2007-09-21 CY CY20071101225T patent/CY1106886T1/el unknown
-
2008
- 2008-10-28 JP JP2008277469A patent/JP4423338B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005503763A5 (enExample) | ||
| CN100441595C (zh) | 结合红细胞生成素受体的新肽 | |
| CN1820024B (zh) | 新的聚(乙二醇)修饰的化合物及其用途 | |
| JP6158235B2 (ja) | 組織保護ペプチド及びその使用 | |
| CN1823088B (zh) | 结合红细胞生成素受体的新肽 | |
| JP3998043B2 (ja) | アゴニストペプチド二量体 | |
| CN102625811B (zh) | Fgf21突变体及其用途 | |
| TWI364295B (en) | Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity | |
| JP2005509609A5 (enExample) | ||
| JP2007500218A (ja) | ポリ（エチレングリコール）修飾ペプチド系化合物の新規スペーサー部分 | |
| JP2000508356A (ja) | 改良型インターフェロン−ポリマーコンジュゲート | |
| KR100334739B1 (ko) | 절단된신경교세포주-유래신경영양성인자단백질산물 | |
| EP1037657A4 (en) | ALPHA INTERFERON-POLYMER CONJUGATES WITH INCREASED BIOLOGICAL EFFECTIVENESS AND METHOD FOR THE PRODUCTION THEREOF | |
| BG62685B1 (bg) | Състави и методи за стимулиране растежа и диференциацията на мегакариоцитите | |
| JP2010534486A5 (enExample) | ||
| HUT77747A (hu) | A BDNF és az NT-3 konjugátumai vízoldható polimerrel képezett konjugátumai | |
| JP2008542399A (ja) | エリスロポエチンレセプターペプチドの処方および使用 | |
| CN1500095B (zh) | 神经胚活素的多聚体偶联物及其应用方法 | |
| CA2311648A1 (en) | Ifnar2/ifn complex | |
| JP2000504586A (ja) | ヘテロ二量体を形成するハイブリッドタンパク質 | |
| CN101880326B (zh) | 干扰素‑β复合物 | |
| RU2007106900A (ru) | Иммуногенные комплексы, способ их приготовления и их применение в фармацевтических композициях | |
| CN101142234A (zh) | 结合红细胞生成素受体的新肽 | |
| CN104672329B (zh) | 一种蛋白质 | |
| JP2004518410A5 (enExample) |